Endocannabinoids protect the rat isolated heart against ischaemia.
about
The endocannabinoid system as an emerging target of pharmacotherapyAnandamide reduces intracellular Ca2+ concentration through suppression of Na+/Ca2+ exchanger current in rat cardiac myocytes.The complexities of the cardiovascular actions of cannabinoidsEndocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusionsEffects of palmitoylethanolamide on aqueous humor outflow.Targeting cannabinoid receptor CB(2) in cardiovascular disorders: promises and controversies.Cannabinoid receptors in acute and chronic complications of atherosclerosis.Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioningCardiovascular pharmacology of cannabinoids.Synthesis and pharmacology of 1-deoxy analogs of CP-47,497 and CP-55,940.Anandamide: an update.Endocannabinoids and liver disease. V. endocannabinoids as mediators of vascular and cardiac abnormalities in cirrhosis.Endocannabinoids and cardiac contractile function: pathophysiological implications.The emerging role of the endocannabinoid system in cardiovascular disease.The potential for clinical use of cannabinoids in treatment of cardiovascular diseases.Endocannabinoids and the cardiovascular response to stress.Cannabinoids and atherosclerotic coronary heart disease.Endocannabinoid system as a potential mechanism for n-3 long-chain polyunsaturated fatty acid mediated cardiovascular protection.Fatty acids and cardiac disease: fuel carrying a message.Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists.Cyclooxygenase metabolism mediates vasorelaxation to 2-arachidonoylglycerol (2-AG) in human mesenteric arteries.Cannabinoid signaling in health and disease.Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS.Electrophysiological effects of anandamide on rat myocardiumRole of endogenous cannabinoids in ischemia/reperfusion injury following testicular torsion in rats.Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism.Anandamide preserves cardiac function and geometry in an acute doxorubicin cardiotoxicity rat model.Effects of N-acylethanolamines on the respiratory chain and production of reactive oxygen species in heart mitochondria.Anandamide enhances expression of heat shock protein 72 to protect against ischemia-reperfusion injury in rat heart.The Endocannabinoid System and Heart Disease: The Role of Cannabinoid Receptor Type 2.Mitochondrial permeability transition pore plays a role in the cardioprotection of CB2 receptor against ischemia-reperfusion injury.
P2860
Q24648473-C0B72825-3440-46EA-A03F-2AE96B232423Q34718132-E52D0115-9083-4A04-B159-5FEAF8B297E3Q35047093-6DB5A6F6-B29B-4D99-AB1C-715C31763C6DQ35228889-2953CDD4-4355-42C1-9A87-3371A07B3703Q36052772-EBA30D9D-385A-497D-8B1C-C3CA3BB5E45EQ36223797-4616A405-042A-4430-A296-70FFDB6AD27EQ36346915-2E81E806-C21E-4B36-819D-79A061314242Q36416368-2ADABA90-5515-4D66-82A3-8C1A2B641A0AQ36416372-D023C150-5422-4B63-B6C2-C50F0C73642DQ36431860-DA35EB9D-EFBB-4277-B273-2CA70188BF11Q36488601-D6FA5FEF-38A5-4DD0-A143-C5807F59AE0BQ36709628-E825FEA5-B916-4CD5-A288-CC23570A1D08Q37243665-E2A14E3D-B490-4E9C-B9CA-6204226E8104Q37401757-F9F32E08-6B91-42E3-97AE-D58B7F6645ADQ37439386-DD3E4B76-EFB2-46ED-91B0-5240BCB4F118Q37800142-83F35891-EE54-4B2C-9C9C-C183FF6E1544Q37894978-7863597B-944E-4C09-A740-331869C2B48EQ37978806-A9300861-2348-4E7B-9F17-3B4C0CAD1670Q38135915-5BC2D596-3B45-4FB4-ABE1-39CC1C123538Q38207743-BDDA583E-4E59-44D2-BA48-5A449DA1BA98Q38612812-BB9952B0-8774-4615-B243-39BFE26B1AD1Q38832242-512C2972-198E-4631-B25B-012A455CBB71Q39163671-5FA007C0-6985-4EF5-8727-76FB58A7DA40Q39784439-17F9D5CF-C7BD-4895-BDB5-D50B9C599227Q41952535-DF0BF758-0F3C-44F1-8B90-F7A60EC94350Q42435550-9A4C2EEB-B126-4C7D-BD6C-5D1786064770Q42844430-96067B9C-C812-4252-80B9-0351AA094C61Q46171847-02FAE1F5-499C-4A2E-A735-CE947A2AD9A3Q46649595-4FE87C75-738D-4862-B8B7-555ADD7CF834Q46810864-10F0B7C3-24E2-4D53-8353-8CE8DF19463BQ50142905-5156478D-9CB8-4CA2-834D-032A3460D9DEQ54373339-2FB3551B-B04E-44FE-8028-7B9A1ACD7BDC
P2860
Endocannabinoids protect the rat isolated heart against ischaemia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Endocannabinoids protect the rat isolated heart against ischaemia.
@en
Endocannabinoids protect the rat isolated heart against ischaemia.
@nl
type
label
Endocannabinoids protect the rat isolated heart against ischaemia.
@en
Endocannabinoids protect the rat isolated heart against ischaemia.
@nl
prefLabel
Endocannabinoids protect the rat isolated heart against ischaemia.
@en
Endocannabinoids protect the rat isolated heart against ischaemia.
@nl
P2093
P2860
P356
P1476
Endocannabinoids protect the rat isolated heart against ischaemia.
@en
P2093
Caroline Lagneux
Daniel Lamontagne
Jean-François Bouchard
Philippe Lépicier
P2860
P304
P356
10.1038/SJ.BJP.0705313
P407
P577
2003-06-01T00:00:00Z